1-5 of 5
Yanyun Li
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation

Arielle Elkrief, Nicholas R. Waters, Natalie Smith, Angel Dai, John Slingerland, Nathan Aleynick, Binita Febles, Pooja Gogia, Nicholas D. Socci, Melissa Lumish, Paul A. Giardina, Jamie E. Chaft, Juliana Eng, Robert J. Motzer, Robin B. Mendelsohn, Kate A. Markey, Mingqiang Zhuang, Yanyun Li, Zhifan Yang, Travis J. Hollmann, Charles M. Rudin, Marcel R.M. van den Brink, Jinru Shia, Susan DeWolf, Adam J. Schoenfeld, Matthew D. Hellmann, N. Esther Babady, David M. Faleck, Jonathan U. Peled
Journal: Cancer Immunology Research
Cancer Immunol Res (2024) 12 (3): 308–321.
https://doi.org/10.1158/2326-6066.CIR-23-0498
Published: 04 March 2024
View article titled, Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation
Open the PDF for Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation in another window
Includes: Supplementary data
Journal Articles

Tumor MHC Class I Expression Associates with Intralesional IL2 Response in Melanoma

Maryam Pourmaleki, Caitlin J. Jones, Charlotte E. Ariyan, Zheng Zeng, Mono Pirun, Daniel A. Navarrete, Yanyun Li, Mianlei Zhang, Subhiksha Nandakumar, Carl Campos, Saad Nadeem, David S. Klimstra, Claire F. Temple-Oberle, Thomas Brenn, Evan J. Lipson, Kara M. Schenk, Julie E. Stein, Janis M. Taube, Michael G. White, Raymond Traweek, Jennifer A. Wargo, John M. Kirkwood, Billel Gasmi, Stephanie L. Goff, Alex D. Corwin, Elizabeth McDonough, Fiona Ginty, Margaret K. Callahan, Andrea Schietinger, Nicholas D. Socci, Ingo K. Mellinghoff, Travis J. Hollmann
Journal: Cancer Immunology Research
Cancer Immunol Res (2022) 10 (3): 303–313.
https://doi.org/10.1158/2326-6066.CIR-21-1083
Published: 01 March 2022
View article titled, Tumor MHC Class I Expression Associates with Intralesional IL2 Response in Melanoma
Open the PDF for Tumor MHC Class I Expression Associates with Intralesional IL2 Response in Melanoma in another window
Includes: Supplementary data
Journal Articles

Abstract PR01: Mechanistic rationale to combine GITR agonism with PD-1 blockade in cancer patients

Roberta Zappasodi, Cynthia Sirard, Yanyun Li, Sadna Budhu, Moshen Abu-Akeel, Cailian Liu, Xia Yang, Hong Zhong, Walter Newman, Jinjin Qi, Phillip Wong, David Schaer, Henry Koon, Vamsidhar Velcheti, Michael Postow, Margaret K Callahan, Jedd D. Wolchok, Taha D. Merghoub
Journal: Cancer Immunology Research
Cancer Immunol Res (2019) 7 (2_Supplement): PR01.
https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR18-PR01
Published: 01 February 2019
View article titled, Abstract PR01: Mechanistic rationale to combine GITR agonism with PD-1 blockade in cancer patients
Journal Articles

Abstract B09: Heterogeneous fates of metastatic lesions linked to immune escape in an ovarian cancer patient

Alejandro Jiménez-Sánchez, Harini Veeraraghavan, Yanyun Li, Hebert Alberto Vargas, Michael B. Gill, Kay J. Park, Oliver Zivanovic, Jason Konner, Jacob Ricca, Dmitriy Zamarin, Carol Aghajanian, Jedd D. Wolchok, Taha Merghoub, Evis Sala, Alexandra Snyder, Martin L. Miller
Journal: Cancer Immunology Research
Cancer Immunol Res (2017) 5 (3_Supplement): B09.
https://doi.org/10.1158/2326-6074.TUMIMM16-B09
Published: 28 February 2017
View article titled, Abstract B09: Heterogeneous fates of metastatic lesions linked to immune escape in an ovarian cancer patient
Journal Articles

Abstract B059: Local intratumoral treatment with low-dose CD40 and TLR4 agonists overcomes resistance to PD-1 blockade to regress tumors systemically

Danny N. Khalil, Luis Felipe Campesato, Yanyun Li, Taha Merghoub, Jedd D. Wolchok
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (11_Supplement): B059.
https://doi.org/10.1158/2326-6066.IMM2016-B059
Published: 31 October 2016
View article titled, Abstract B059: Local intratumoral treatment with low-dose CD40 and TLR4 agonists overcomes resistance to PD-1 blockade to regress tumors systemically